Glucagon Kit
Product Images NDC 85766-043

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 85766-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Emperical-formula (Emprical Formula)

Emperical-formula (Emprical Formula)
Chemical structure diagram showing the amino acid sequence of glucagon, a peptide hormone. The sequence is displayed in a semi-circular layout, with each amino acid residue represented by its three-letter code and numbered positions along the chain.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph plotting blood glucose concentrations (mg/dL) over time (hours). The graph shows an initial rise in glucose levels peaking around 0.5 hours, followed by a gradual decline and stabilization between 1.5 and 4 hours.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph illustrating glucagon concentration (ng/mL) over time (hours). The graph shows a rapid increase in glucagon concentration peaking around 0.5 hours, followed by a gradual decline back to near zero by 4 hours. Error bars indicate variability at each time point.*
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
An illustration of the Glucagon kit components including a vial containing powder with rubber stopper and flip-off seal, a needle with protector, and a prefilled syringe containing diluent with plunger, backstop, and plastic clip. Each part is labeled and displayed in sequence.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
An instructional line drawing labeled Figure B shows a hand holding a syringe. An arrow above the syringe indicates an upward movement, likely demonstrating how to pull or remove the syringe cap.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
Illustration depicting a hand holding a syringe and vial, demonstrating how to draw medication from the vial into the syringe. Labeled as Figure C, this diagram is part of instructions for preparing the Glucagon kit by Sportpharm LLC.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
An instructional illustration labeled Figure D showing a hand grasping a small component and twisting it in the indicated direction, represented by a circular arrow. This diagram is likely part of usage instructions for the Glucagon kit by Sportpharm LLC.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
Illustration labeled Figure E depicting two hands preparing a syringe by attaching a needle or accessory to the syringe barrel, with a downward-pointing arrow indicating motion or direction during assembly.*
FDA Label Image

1 (Label Glucagon Inj)

1 (Label Glucagon Inj)
Packaging label for Glucagon for Injection USP 1 mg per vial kit, relabeled for Sportpharm LLC. The label shows NDC 85766-043-01 with quantity 1. It states the product is manufactured for Cipla USA, Inc. and includes storage, batch, and lot information areas along with caution and drug status instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.